TNFSF10 and gastric carcinoma: In contrast to the work by Koyama et al. [37] that reported a TRAIL protein expression in 55.6 % of the cells from primary gastric carcinomas and 53.7 % of the cells from metastatic gastric carcinomas, respectively, we were able to detect TRAIL in all gastric carcinoma samples on mRNA levels.